AGT and cardiac hypertrophy: We established in vivo and in vitro models of cardiac hypertrophy via TAC and Ang-II treatment, respectively, and observed a significant increase in pyroptotic cells, along with upregulation in IL-1β, cleaved caspase-1, and GSDMD-N.